Aptevo Therapeutics Inc. Lease, Cost
Aptevo Therapeutics Inc. (APVO) reported Lease, Cost of $297.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-14
- Aptevo Therapeutics Inc. lease, cost for the quarter ending 2026-06-30 was $297.00K, a 0.00% change year-over-year.
- Aptevo Therapeutics Inc. lease, cost for the quarter ending 2026-03-31 was $297.00K, a 0.00% change year-over-year.
- Aptevo Therapeutics Inc. lease, cost for the quarter ending 2025-09-30 was $297.00K, a 0.00% change year-over-year.
- Aptevo Therapeutics Inc. lease, cost for the quarter ending 2025-06-30 was $297.00K, a 0.00% change year-over-year.
- Aptevo Therapeutics Inc. lease, cost for fiscal 2024 was $1.19M, a 0.00% change from fiscal 2023.
- Aptevo Therapeutics Inc. lease, cost for fiscal 2023 was $1.19M, a 7.05% decline from fiscal 2022.
- Aptevo Therapeutics Inc. lease, cost for fiscal 2022 was $1.28M, a 17.93% decline from fiscal 2021.
- Aptevo Therapeutics Inc. lease, cost for fiscal 2021 was $1.56M, a 1.95% decline from fiscal 2020.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 9 month as first filed | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $297.00K 10-Q · filed 2026-08-14 | $594.00K 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | $297.00K 10-Q · filed 2026-05-13 | |||||||
| 2025-09-30 | $297.00K 10-Q · filed 2025-11-06 | $594.00K derived: sum of 2 quarters · filed 2026-08-14 | $890.00K 10-Q · filed 2025-11-06 | $1.19M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $297.00K 10-Q · filed 2026-08-14 | $594.00K 10-Q · filed 2026-08-14 | $891.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.19M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $297.00K 10-Q · filed 2026-05-13 | $594.00K derived: sum of 2 quarters · filed 2026-05-13 | $891.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.19M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $594.00K derived: sum of 2 quarters · filed 2025-11-06 | $891.00K derived: sum of 3 quarters · filed 2025-11-06 | $1.19M 10-K · filed 2025-02-14 | ||||
| 2024-09-30 | $297.00K 10-Q · filed 2025-11-06 | $594.00K derived: sum of 2 quarters · filed 2025-11-06 | $890.00K 10-Q · filed 2025-11-06 | $1.19M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $297.00K 10-Q · filed 2025-08-11 | $594.00K 10-Q · filed 2025-08-11 | $891.00K derived: sum of 3 quarters · filed 2025-08-11 | $1.19M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $297.00K 10-Q · filed 2025-05-15 | $594.00K derived: sum of 2 quarters · filed 2025-05-15 | $891.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.19M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $594.00K derived: sum of 2 quarters · filed 2025-02-14 | $891.00K derived: sum of 3 quarters · filed 2025-02-14 | $1.19M 10-K · filed 2025-02-14 | ||||
| 2023-09-30 | $297.00K 10-Q · filed 2024-11-07 | $594.00K derived: sum of 2 quarters · filed 2024-11-07 | $890.00K 10-Q · filed 2024-11-07 | $1.19M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $297.00K 10-Q · filed 2024-08-08 | $594.00K 10-Q · filed 2024-08-08 | $893.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.19M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $297.00K 10-Q · filed 2024-05-08 | $596.00K derived: sum of 2 quarters · filed 2024-05-08 | $895.00K derived: sum of 3 quarters · filed 2024-05-08 | $1.21M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $598.00K derived: sum of 2 quarters · filed 2024-03-05 | $917.00K derived: sum of 3 quarters · filed 2024-03-05 | $1.28M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $299.00K 10-Q · filed 2023-11-14 | $618.00K derived: sum of 2 quarters · filed 2023-11-14 | $978.00K 10-Q · filed 2023-11-14 | $980.00K 10-Q · filed 2022-11-10 | $1.34M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $319.00K 10-Q · filed 2023-08-10 | $320.00K 10-Q · filed 2022-08-11 | $679.00K 10-Q · filed 2023-08-10 | $681.00K 10-Q · filed 2022-08-11 | $1.04M derived: sum of 3 quarters · filed 2023-08-10 | $1.44M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $360.00K 10-Q · filed 2023-05-11 | $362.00K 10-Q · filed 2022-05-12 | $726.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.12M derived: sum of 3 quarters · filed 2023-05-11 | $1.52M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $763.00K derived: sum of 2 quarters · filed 2023-03-30 | $1.16M derived: sum of 3 quarters · filed 2023-03-30 | $1.56M 10-K · filed 2023-03-30 | $1.56M 10-K · filed 2022-03-24 | |||
| 2021-09-30 | $397.00K 10-Q · filed 2022-11-10 | $793.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.19M 10-Q · filed 2022-11-10 | $1.59M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $396.00K 10-Q · filed 2022-08-11 | $793.00K 10-Q · filed 2022-08-11 | $1.19M derived: sum of 3 quarters · filed 2022-08-11 | $1.59M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $397.00K 10-Q · filed 2022-05-12 | $793.00K derived: sum of 2 quarters · filed 2022-05-12 | $1.19M derived: sum of 3 quarters · filed 2022-05-12 | $1.59M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $793.00K derived: sum of 2 quarters · filed 2022-03-24 | $1.19M derived: sum of 3 quarters · filed 2022-03-24 | $1.59M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $397.00K 10-Q · filed 2021-11-12 | $794.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.19M 10-Q · filed 2021-11-12 | $1.59M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $397.00K 10-Q · filed 2021-08-12 | $793.00K 10-Q · filed 2021-08-12 | $1.19M derived: sum of 3 quarters · filed 2021-08-12 | $1.59M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $397.00K 10-Q · filed 2021-05-11 | $796.00K derived: sum of 2 quarters · filed 2021-05-11 | $1.19M derived: sum of 3 quarters · filed 2021-05-11 | $1.59M derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | $399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $797.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.20M derived: sum of 3 quarters · filed 2021-03-31 | $1.53M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $398.00K 10-Q · filed 2020-11-10 | $799.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.14M 10-Q · filed 2020-11-10 | |||||
| 2019-06-30 | $401.00K 10-Q · filed 2020-08-14 | $738.00K 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | $337.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |